Special Issue "Advanced Nanopharmaceutics for Anticancer Therapy"

A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Targeting and Design".

Deadline for manuscript submissions: 10 August 2023 | Viewed by 86

Special Issue Editors

Institute of Biophysics and Informatics, First Faculty of Medicine, Charles University, Salmovska 1, 120 00 Prague 2, Czech Republic
Interests: cancer immunotherapy; drug delivery; gene therapy; cancer immunology
Special Issues, Collections and Topics in MDPI journals
Department of Biomedical Polymers, Institute of Macromolecular Chemistry CAS , Heyrovského nám. 2, 162 00 Prague 6, Czech Republic
Interests: nanotherapeutics; drug delivery; cancer; tumor

Special Issue Information

Dear Colleagues,

Over several decades, nanomedicines have achieved great advances in medical applications, especially in cancer therapy. Nano-sized drug delivery systems based on polymers, proteins, and lipids provide a flexible platform for binding therapeutic and/or diagnostic agents and delivering them to the target tissue. The smart design of these nanocarriers improves the delivery efficiency and site-specific controlled release of therapeutic agents. Recently, many studies have focused on (besides chemotherapy delivery) delivering cancer vaccines and immunotherapy and/or utilizing nanocarriers for diagnostic purposes such as delivering contrast agents for SPECT, PET, and MRI imaging or developing theranostic probes for image-guided resection.

Authors are kindly invited to submit original papers, reviews, and communications regarding recent advances in nanocarriers designed for anticancer drug delivery applications, diagnosis, their characterization, as well as in vitro, in vivo, clinical, or in silico testing to be published in this Special Issue of Pharmaceutics.

Dr. David Větvička
Dr. Martin Studenovský
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • nanomaterials 
  • drug delivery systems 
  • cancer therapy 
  • polymer carriers 
  • liposomes 
  • theranostics 
  • imaging 
  • tumor targeting 
  • biomaterials

Published Papers

This special issue is now open for submission.
Back to TopTop